RxDoctor Payments Data

Megan Murdock

Family · Lenexa, KSNPI 1750979472

Payments from drug & device makers

$3,907in general payments, 2019–2025

Across 229 payments — averaging $17.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Lilly USA, LLC$718
  • AstraZeneca$436
  • Novo Nordisk$188
  • Ardelyx, Inc.$112
  • Boehringer Ingelheim$88
  • plus $1K from 36 others

What the payments were for

  • Food & beverage$3,907100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,907 in reported general payments places this provider in the 90th percentile of 1,579 family providers in Kansas.

See all family providers in Kansas

Most prescribed under Part D

DrugClaimsCost to plans & patients
Albuterol Sulfate HfaAlbuterol Sulfate29$484
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav41$231
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst26$201
Doxycycline Hyclate37$188
Mupirocin25$139
Methylprednisolone17$117
Ciprofloxacin Hcl27$78
Triamcinolone Acetonide18$75
Azithromycin19$50
Prednisone17$20
PaxlovidNirmatrelvir/Ritonavir12$0

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerPaxlovid$46$012 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,579 family providers in Kansas.

Other family in Lenexa

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →